Immune checkpoint inhibitors: a new frontier in bladder cancer

被引：15
|
作者：
Kates, Max [1 ,2 ]
Sopko, Nikolai A. [1 ,2 ]
Matsui, Hotaka [1 ,2 ]
Drake, Charles G. [1 ,2 ]
Hahn, Noah M. [1 ,2 ]
Bivalacqua, Trinity J. [1 ,2 ]
机构：
[1] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, 1800 Orleans St,Marburg 420, Baltimore, MD 21287 USA
[2] Johns Hopkins Sch Med, Dept Urol, 1800 Orleans St,Marburg 420, Baltimore, MD 21287 USA
来源：
WORLD JOURNAL OF UROLOGY | 2016年 / 34卷 / 01期
基金：
美国国家卫生研究院;
关键词：
Immune checkpoint; Bladder cancer; Tumor immunology; BACILLUS-CALMETTE-GUERIN; PD-1; BLOCKADE; UROTHELIAL CARCINOMA; ANTI-PD-L1; ANTIBODY; ANTITUMOR IMMUNITY; ADVANCED MELANOMA; IFN-GAMMA; CTLA-4; EXPRESSION; SAFETY;
D O I：
10.1007/s00345-015-1709-y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Immunotherapy is rapidly changing the field of urologic oncology. In this review, we discuss the role of the immune system in general and place a particular emphasis on the biology of the immune checkpoint and its role in cancer. Bladder cancer, as one of the most immunogenic neoplasms, is an exciting target for immune checkpoint inhibition. Early preclinical data and human trial experience suggest that this new drug class may shape bladder cancer therapy for years to come.
引用
收藏
页码：49 / 55
页数：7
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors: a new frontier in bladder cancer
    Max Kates
    Nikolai A. Sopko
    Hotaka Matsui
    Charles G. Drake
    Noah M. Hahn
    Trinity J. Bivalacqua
    [J]. World Journal of Urology, 2016, 34 : 49 - 55
  • [2] Immune checkpoint inhibitors and prostate cancer: a new frontier?
    Modena, Alessandra
    Ciccarese, Chiara
    Iacovelli, Roberto
    Brunelli, Matteo
    Montironi, Rodolfo
    Fiorentino, Michelangelo
    Tortora, Giampaolo
    Massari, Francesco
    [J]. ONCOLOGY REVIEWS, 2016, 10 (01)
  • [3] Immune checkpoint inhibitors for metastatic bladder cancer
    Cubelli, Marta
    Di Nunno, Vincenzo
    Rihawi, Karim
    Massari, Francesco
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S720 - S732
  • [4] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    [J]. CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
  • [5] Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
    Lopez-Beltran, Antonio
    Cimadamore, Alessia
    Blanca, Ana
    Massari, Francesco
    Vau, Nuno
    Scarpelli, Marina
    Cheng, Liang
    Montironi, Rodolfo
    [J]. CANCERS, 2021, 13 (01) : 1 - 16
  • [6] Immune Checkpoint Inhibitors in AML-A New Frontier
    Thummalapalli, Rohit
    Knaus, Hanna A.
    Gojo, Ivana
    Zeidner, Joshua F.
    [J]. CURRENT CANCER DRUG TARGETS, 2020, 20 (07) : 545 - 557
  • [7] Combining epigenetic and immune checkpoint inhibitors in bladder cancer
    Thoma, Clemens
    [J]. NATURE REVIEWS UROLOGY, 2019, 16 (09) : 507 - 507
  • [8] Combining epigenetic and immune checkpoint inhibitors in bladder cancer
    Clemens Thoma
    [J]. Nature Reviews Urology, 2019, 16 : 507 - 507
  • [9] Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
    Vafaei, Somayeh
    Zekiy, Angelina O.
    Khanamir, Ramadhan Ado
    Zaman, Burhan Abdullah
    Ghayourvahdat, Arman
    Azimizonuzi, Hannaneh
    Zamani, Majid
    [J]. CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [10] Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
    Somayeh Vafaei
    Angelina O. Zekiy
    Ramadhan Ado Khanamir
    Burhan Abdullah Zaman
    Arman Ghayourvahdat
    Hannaneh Azimizonuzi
    Majid Zamani
    [J]. Cancer Cell International, 22
12345